EUVIMEDEUVIMED entdecken
CrossrefInfokarte

LQM10, a guanylhydrazone derivative, reduces nociceptive and inflammatory responses in mice

João Paulo Noé, Jamylle Nunes de Souza‐Ferro, Érica Erlanny da Silva‐Rodrigues, Edeildo Ferreira da Silva‐Júnior, Magna Suzana Alexandre‐Moreira, João Xavier de Araújo‐Junior, Emiliano Barreto

Fundamental & Clinical Pharmacology · 2023-06 · 37 (3) · 619-628

DOI: 10.1111/fcp.12862 ↗
AbstractBibliografische Angaben

Abstract

Abstract In the present study, we examined the antinociceptive and anti‐inflammatory activities of a guanylhydrazone derivative, ( E )‐(3,5‐di‐ tert ‐butyl‐4‐hydroxybenzylidene)‐2‐guanylhydrazone hydrochloride (LQM10), in mice. The antinociceptive effect was determined by assessing behavioural responses in different pain models, while anti‐inflammatory activity was examined in carrageenan‐induced pleurisy. Intraperitoneal LQM10 administration reduced the acetic acid‐induced nociceptive behaviour, a phenomenon that was unaltered by pretreatment with yohimbine, atropine, naloxone or glibenclamide. In the formalin assay, LQM10 reduced nociceptive behaviour only in the second phase, indicating an inhibitory effect on inflammatory pain. LQM10 did not alter the pain latency in the hot plate assay and did not impact the locomotor activity of mice in the rotarod assay. In the carrageenan‐induced pleurisy assay, LQM10 treatment inhibited critical events involved in inflammatory responses, namely, leucocyte recruitment, plasma leakage and increased inflammatory mediators (tumour necrosis factor Like Properties of Chalchones and Flavonoid Derivatives [TNF]‐α and interleukin [IL]‐1β) in the pleural exudate. Overall, these results indicate that LQM10 exhibits antinociceptive effects associated with peripheral mechanisms and anti‐inflammatory activity mediated via a reduction in leucocyte migration and proinflammatory mediators, rendering this compound a promising candidate for treating pain and inflammatory process.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →